EP2200431
Nýjungar í efnasamsetningum og aðferðum við krabbameinsmeðferð
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
10.9.2008EP published:
20.7.2016EP application number:
08830633.7
EP translation filed:
27.7.2016Grant published:
15.8.2016EPO information:
European Patent Register
Max expiry date:
9.9.2028Expiry date:
9.9.2024
Title:
NOVEL COMPOSITIONS AND METHODS FOR CANCER TREATMENT
Timeline
Today
10.9.2008EP application
20.7.2016EP Publication
27.7.2016Translation submitted
15.8.2016Registration published
9.9.2024Expires
Owner
Name:
Boston Biomedical, Inc.Address:
640 Memorial Drive, 02139, Cambridge, MA, US
Inventor
Name:
LI, Chiang, JiaAddress:
Cambridge, MA, US
Name:
MIKULE, KeithAddress:
CambridgeMA, US
Name:
LI, YouzhiAddress:
WestwoodMA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
971144 PDate:
10.9.2007Country:
US
Number:
13372Date:
13.12.2007Country:
US
Classification
Categories:
A61K 31/505, A61K 31/55, A61K 38/17, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 22.9.2016
Expires: 9.9.2017
Payer: Árnason Faktor
Number: 10
Paid: 12.9.2017
Expires: 9.9.2018
Payer: G. H. Sigurgeirsson
Number: 11
Paid: 13.8.2018
Expires: 9.9.2019
Payer: Örn Þór, slf.
Number: 12
Paid: 19.9.2019
Expires: 9.9.2020
Payer: Guðjón Styrkársson, hrl.
Number: 13
Paid: 22.9.2020
Expires: 9.9.2021
Payer: Patice ehf.
Number: 14
Paid: 17.9.2021
Expires: 9.9.2022
Payer: Patice ehf.
Number: 15
Paid: 16.9.2022
Expires: 9.9.2023
Payer: Patice ehf.
Number: 16
Paid: 25.9.2023
Expires: 9.9.2024
Payer: Árnason Faktor ehf.